Henderson Molly's Form 4 filing
Phathom Pharmaceuticals, Inc. (PHAT) · filed Apr 10, 2024
- Accession no.
- 0000950170-24-043385
- Filed
- Apr 10, 2024
- Trade date
- Apr 8, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $38.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Henderson MollyCIK 0001363812 | Officer (CFO and CBO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 8, 2024 | Common Stoock | SSaleDisposed | −3,435 | $11.10 | −$38,128.5 | 95,263 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.